effects [qlco]
Androgens+anabolic steroids [phsu]
Apolipoproteins [aapp, bacs]
Lipoprotein (a) [aapp, bacs]
objectives [inpr]
investigate [ftcn]
effects [qlco]
regimens [inpr]
Androgenic steroid [horm, strd]
anabolic [phsu, strd]
Administration [ocac]
serum lipid [lbpr]
Lipoproteins [aapp, bacs]
Recovery [acty]
variables [qlco]
Drug [phsu]
Cessation [acty]
Indicators [irda]
Cardiovascular disease [dsyn]
Health [idcn]
Strength [qnco]
Athletes [prog]
Methods [inpr]
blinded study [resa]
Study [mnob]
Lipoproteins [aapp, bacs]
Lipids [lipd]
Assessed [acty]
Subject [grup]
Self-Administered [ftcn]
AASS [gngm]
Eight [qnco]
weeks [tmco]
Volunteers [prog]
DOUBLE BLIND [resa]
placebo-controlled [resa]
Design [acty]
effects [qlco]
INTRAMUSCULAR [ftcn]
Administration [ocac]
nandrolone decanoate [horm, phsu, strd]
mg% [qnco]
Eight [qnco]
weeks [tmco]
Same [qlco]
variables [qlco]
Study [mnob]
Study [mnob]
Fasting [fndg]
serum concentration [qnco]
Total Cholesterol [lbpr]
Triglycerides [bacs, lipd]
Cholesterol, HDL [bacs, lipd]
Cholesterol, HDL2 [bacs, strd]
Cholesterol, HDL3 [bacs, strd]
Apolipoprotein A-I [aapp, bacs]
Apolipoprotein B [aapp, bacs]
Lipoprotein (a) [aapp, bacs]
Lp(a) [aapp, bacs]
In [qnco]
Study [mnob]
Anabolic steroid [phsu, strd]
Administration [ocac]
LED [mnob]
decreases [qnco]
serum concentration [qnco]
Cholesterol, HDL [bacs, lipd]
mmol/L [qnco]
Cholesterol, HDL2 [bacs, strd]
mmol/L [qnco]
Cholesterol, HDL3 [bacs, strd]
mmol/L [qnco]
Apolipoprotein A-I [aapp, bacs]
g l [qnco]
Apolipoprotein B [aapp, bacs]
Increased [qnco]
g l [qnco]
Lp(a) [aapp, bacs]
U/L [qnco]
Total Cholesterol [lbpr]
Triglycerides [bacs, lipd]
Alteration [idcn]
Eight [qnco]
weeks [tmco]
Anabolic steroid [phsu, strd]
Administration [ocac]
Occurred [acty]
Six [qnco]
weeks [tmco]
Anabolic steroid [phsu, strd]
Cessation [acty]
Serum HDL Cholesterol [lbpr]
Cholesterol, HDL2 [bacs, strd]
Apolipoprotein A-I [aapp, bacs]
Apolipoprotein B [aapp, bacs]
Lp(a) [aapp, bacs]
Return [qlco]
baseline [bodm]
Concentrations [menp]
Administration [ocac]
Anabolic steroid [phsu, strd]
weeks [tmco]
Slow [qlco]
Recovery [acty]
Pretreatment [sbst]
Concentrations [menp]
Administration [ocac]
Eight [qnco]
weeks [tmco]
In [qnco]
Study [mnob]
nandrolone decanoate [horm, phsu, strd]
serum triglycerides [lbpr]
Total Cholesterol [lbpr]
Cholesterol, HDL [bacs, lipd]
Cholesterol, HDL2 [bacs, strd]
Cholesterol, HDL3 [bacs, strd]
Apolipoprotein A-I [aapp, bacs]
Apolipoprotein B [aapp, bacs]
Concentrations [menp]
Eight [qnco]
weeks [tmco]
intervention [hlca]
Six [qnco]
weeks [tmco]
Withdrawal [acty]
Lp(a) [aapp, bacs]
Concentrations [menp]
Decreased [qnco]
U/L [qnco]
nandrolone decanoate [horm, phsu, strd]
Group [idcn]
placebo [topp]
Group [idcn]
Smaller [qlco]
reduction [npop]
U/L [qnco]
Observed [ftcn]
Six [qnco]
weeks [tmco]
intervention [hlca]
Lp(a) [aapp, bacs]
Concentrations [menp]
Return [qlco]
baseline [bodm]
Values [qlco]
Group [idcn]
Conclusions [idcn]
Self Administration [topp]
Several [qnco]
AASS [gngm]
simultaneously [tmco]
Eight [qnco]
weeks [tmco]
Profound [qlco]
Unfavorable [qlco]
effects [qlco]
Lipids [lipd]
Lipoproteins [aapp, bacs]
Leading [tmco]
Increased lipid [fndg]
Atherogenesis [patf]
Profile [lbpr]
Lp(a) [aapp, bacs]
Concentration [menp]
Anabolic steroid [phsu, strd]
Withdrawal [acty]
Normalization [resa]
depend [medd]
Duration [tmco]
Drug abuse [mobd]
Eight [qnco]
weeks [tmco]
Administration [ocac]
nandrolone decanoate [horm, phsu, strd]
Affect [menp]
Lipid [lipd]
Lipoprotein [aapp, bacs]
Concentrations [menp]
Lp(a) [aapp, bacs]
Concentrations [menp]
On [ftcn]
Atherogenesis [patf]
Established [qlco]
